CorMedix Inc
CRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$611.86M
Close$
$-0.37
104.7% downside
Current Fair Value
104.7% downsideOvervalued by 104.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $611.86 Million |
|---|---|
| Enterprise Value | $500.32 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $2.25 |
| Beta | 1.41 |
| Outstanding Shares | 78,444,000 |
Return
| Return on Equity | 23575.05% |
|---|---|
| Return on Assets | 12017.18% |
| Return on Invested Capital | 7491.85% |
Valuation & Multiples
| P/E Ratio | 3.26 |
|---|---|
| PEG | 10.48 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 1.57 |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | 0.01 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.29 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$96.04 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$53.23 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 79.19% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.89%▼ 55.25% |
|---|---|
| Total Invested | $5.34M▼ 98.48% |
| Investors Holding | 10▼ 195.00% |
ESG Score
No data
About CorMedix Inc
CEO: Khoso Baluch